Which has better earnings & valuation, SGHT or INMD?

InMode has higher revenue and earnings than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sight Sciences $77.36M 3.39 -$38.43M -$0.71 N/A InMode $370.49M 2.30 $93.83M $1.36 9.90

Is SGHT or INMD more profitable?

InMode has a net margin of 23.27% compared to Sight Sciences' net margin of -46.83%. InMode's return on equity of 13.47% beat Sight Sciences' return on equity. Company Net Margins Return on Equity Return on Assets Sight Sciences -46.83% -52.34% -28.49% InMode 23.27% 13.47% 11.95%

Is SGHT or CBLL more profitable?

Sight Sciences has a net margin of -46.83% compared to CeriBell's net margin of -63.51%. CeriBell's return on equity of -38.19% beat Sight Sciences' return on equity. Company Net Margins Return on Equity Return on Assets Sight Sciences -46.83% -52.34% -28.49% CeriBell -63.51% -38.19% -30.92%

Sight Sciences (SGHT) Competitors

$4.82 -0.03 (-0.62%)

Closing price 04:00 PM Eastern

Extended Trading

$4.82 0.00 (0.00%)

As of 04:10 PM Eastern

Compare

SGHT vs. AVR, DRTS, INMD, SSII, and CBLL

Should you buy Sight Sciences stock or one of its competitors? MarketBeat compares Sight Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sight Sciences include Anteris Technologies Global (AVR), Alpha Tau Medical (DRTS), InMode (INMD), SS Innovations International (SSII), and CeriBell (CBLL). These companies are all part of the "medical equipment" industry.

How does Sight Sciences compare to Anteris Technologies Global?

Anteris Technologies Global (NASDAQ:AVR) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk and institutional ownership.

55.5% of Sight Sciences shares are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by company insiders. Comparatively, 28.9% of Sight Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Anteris Technologies Global presently has a consensus target price of $16.00, indicating a potential upside of 68.42%. Sight Sciences has a consensus target price of $8.14, indicating a potential upside of 68.96%. Given Sight Sciences' higher possible upside, analysts clearly believe Sight Sciences is more favorable than Anteris Technologies Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Sight Sciences	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44

Sight Sciences has higher revenue and earnings than Anteris Technologies Global. Sight Sciences is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	484.15	-$94.14M	-$2.23	N/A
Sight Sciences	$77.36M	3.39	-$38.43M	-$0.71	N/A

In the previous week, Anteris Technologies Global had 9 more articles in the media than Sight Sciences. MarketBeat recorded 10 mentions for Anteris Technologies Global and 1 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 1.87 beat Anteris Technologies Global's score of 0.71 indicating that Sight Sciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Anteris Technologies Global	Positive
Sight Sciences	Very Positive

Sight Sciences has a net margin of -46.83% compared to Anteris Technologies Global's net margin of -5,148.78%. Sight Sciences' return on equity of -52.34% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%
Sight Sciences	-46.83%	-52.34%	-28.49%

Anteris Technologies Global has a beta of 1.78, meaning that its share price is 78% more volatile than the broader market. Comparatively, Sight Sciences has a beta of 2.41, meaning that its share price is 141% more volatile than the broader market.

Summary

Sight Sciences beats Anteris Technologies Global on 12 of the 16 factors compared between the two stocks.

How does Sight Sciences compare to Alpha Tau Medical?

Sight Sciences (NASDAQ:SGHT) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

Alpha Tau Medical has a net margin of 0.00% compared to Sight Sciences' net margin of -46.83%. Sight Sciences' return on equity of -52.34% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sight Sciences	-46.83%	-52.34%	-28.49%
Alpha Tau Medical	N/A	-73.23%	-52.90%

Sight Sciences presently has a consensus target price of $8.14, indicating a potential upside of 68.96%. Alpha Tau Medical has a consensus target price of $12.60, indicating a potential upside of 36.36%. Given Sight Sciences' stronger consensus rating and higher possible upside, research analysts clearly believe Sight Sciences is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sight Sciences	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44
Alpha Tau Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

55.5% of Sight Sciences shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 28.9% of Sight Sciences shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sight Sciences has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sight Sciences	$77.36M	3.39	-$38.43M	-$0.71	N/A
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A

In the previous week, Alpha Tau Medical had 3 more articles in the media than Sight Sciences. MarketBeat recorded 4 mentions for Alpha Tau Medical and 1 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 1.87 beat Alpha Tau Medical's score of -0.12 indicating that Sight Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
Sight Sciences	Very Positive
Alpha Tau Medical	Neutral

Sight Sciences has a beta of 2.41, suggesting that its share price is 141% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market.

Summary

Sight Sciences beats Alpha Tau Medical on 11 of the 15 factors compared between the two stocks.

How does Sight Sciences compare to InMode?

Sight Sciences (NASDAQ:SGHT) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

55.5% of Sight Sciences shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 28.9% of Sight Sciences shares are owned by company insiders. Comparatively, 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

InMode has a net margin of 23.27% compared to Sight Sciences' net margin of -46.83%. InMode's return on equity of 13.47% beat Sight Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sight Sciences	-46.83%	-52.34%	-28.49%
InMode	23.27%	13.47%	11.95%

Sight Sciences presently has a consensus target price of $8.14, indicating a potential upside of 68.96%. InMode has a consensus target price of $16.00, indicating a potential upside of 18.78%. Given Sight Sciences' stronger consensus rating and higher probable upside, research analysts plainly believe Sight Sciences is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sight Sciences	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, InMode had 1 more articles in the media than Sight Sciences. MarketBeat recorded 2 mentions for InMode and 1 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 1.87 beat InMode's score of 0.63 indicating that Sight Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
Sight Sciences	Very Positive
InMode	Positive

Sight Sciences has a beta of 2.41, meaning that its share price is 141% more volatile than the broader market. Comparatively, InMode has a beta of 1.94, meaning that its share price is 94% more volatile than the broader market.

InMode has higher revenue and earnings than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sight Sciences	$77.36M	3.39	-$38.43M	-$0.71	N/A
InMode	$370.49M	2.30	$93.83M	$1.36	9.90

Summary

InMode beats Sight Sciences on 9 of the 16 factors compared between the two stocks.

How does Sight Sciences compare to SS Innovations International?

Sight Sciences (NASDAQ:SGHT) and SS Innovations International (NASDAQ:SSII) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability.

SS Innovations International has a net margin of -20.69% compared to Sight Sciences' net margin of -46.83%. SS Innovations International's return on equity of -23.00% beat Sight Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sight Sciences	-46.83%	-52.34%	-28.49%
SS Innovations International	-20.69%	-23.00%	-13.18%

Sight Sciences presently has a consensus price target of $8.14, indicating a potential upside of 68.96%. SS Innovations International has a consensus price target of $7.00, indicating a potential upside of 98.86%. Given SS Innovations International's higher probable upside, analysts clearly believe SS Innovations International is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sight Sciences	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, SS Innovations International had 2 more articles in the media than Sight Sciences. MarketBeat recorded 3 mentions for SS Innovations International and 1 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 1.87 beat SS Innovations International's score of 0.72 indicating that Sight Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
Sight Sciences	Very Positive
SS Innovations International	Positive

SS Innovations International has lower revenue, but higher earnings than Sight Sciences. SS Innovations International is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sight Sciences	$77.36M	3.39	-$38.43M	-$0.71	N/A
SS Innovations International	$42.49M	16.58	-$12.13M	-$0.05	N/A

Sight Sciences has a beta of 2.41, suggesting that its share price is 141% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.88, suggesting that its share price is 288% less volatile than the broader market.

55.5% of Sight Sciences shares are held by institutional investors. 28.9% of Sight Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Sight Sciences and SS Innovations International tied by winning 8 of the 16 factors compared between the two stocks.

How does Sight Sciences compare to CeriBell?

Sight Sciences (NASDAQ:SGHT) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

In the previous week, CeriBell had 3 more articles in the media than Sight Sciences. MarketBeat recorded 4 mentions for CeriBell and 1 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 1.87 beat CeriBell's score of 0.87 indicating that Sight Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
Sight Sciences	Very Positive
CeriBell	Positive

Sight Sciences has higher earnings, but lower revenue than CeriBell. CeriBell is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sight Sciences	$77.36M	3.39	-$38.43M	-$0.71	N/A
CeriBell	$89.06M	7.83	-$53.41M	-$1.63	N/A

Sight Sciences has a beta of 2.41, indicating that its share price is 141% more volatile than the broader market. Comparatively, CeriBell has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

55.5% of Sight Sciences shares are held by institutional investors. 28.9% of Sight Sciences shares are held by insiders. Comparatively, 20.1% of CeriBell shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Sight Sciences has a net margin of -46.83% compared to CeriBell's net margin of -63.51%. CeriBell's return on equity of -38.19% beat Sight Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sight Sciences	-46.83%	-52.34%	-28.49%
CeriBell	-63.51%	-38.19%	-30.92%

Sight Sciences currently has a consensus price target of $8.14, suggesting a potential upside of 68.96%. CeriBell has a consensus price target of $22.20, suggesting a potential upside of 20.78%. Given Sight Sciences' higher probable upside, equities research analysts plainly believe Sight Sciences is more favorable than CeriBell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sight Sciences	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44
CeriBell	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83

Summary

Sight Sciences beats CeriBell on 11 of the 17 factors compared between the two stocks.

Get Sight Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SGHT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SGHT vs. The Competition

Export

Metric	Sight Sciences	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$262.26M	$7.10B	$6.43B	$11.71B
Dividend Yield	N/A	1.20%	2.67%	5.55%
P/E Ratio	-6.79	46.97	24.49	23.62
Price / Sales	3.39	73.08	500.49	105.27
Price / Cash	N/A	24.77	42.36	56.09
Price / Book	3.98	6.93	10.43	6.70
Net Income	-$38.43M	$159.22M	$3.56B	$337.26M
7 Day Performance	11.06%	-1.91%	-1.38%	-1.41%
1 Month Performance	-10.41%	3.26%	0.86%	1.15%
1 Year Performance	15.59%	-2.82%	19.43%	22.61%

Sight Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SGHT Sight Sciences	3.0327 of 5 stars	$4.82 -0.6%	$8.14 +69.0%	+19.5%	$262.26M	$77.36M	N/A	210	Positive News
AVR Anteris Technologies Global	3.6925 of 5 stars	$9.29 +2.1%	$16.00 +72.2%	+76.4%	$885.81M	$1.91M	N/A	138
DRTS Alpha Tau Medical	3.3379 of 5 stars	$8.93 -7.6%	$12.20 +36.6%	+193.6%	$873M	N/A	N/A	80
INMD InMode	2.8925 of 5 stars	$13.50 -0.7%	$16.00 +18.5%	-6.9%	$861.04M	$370.49M	9.93	480
SSII SS Innovations International	2.8036 of 5 stars	$4.01 +1.8%	N/A	-22.3%	$788.52M	$42.49M	N/A	4	Positive News High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SGHT) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sight Sciences (SGHT) Competitors

SGHT vs. AVR, DRTS, INMD, SSII, and CBLL

How does Sight Sciences compare to Anteris Technologies Global?

Summary

How does Sight Sciences compare to Alpha Tau Medical?

Summary

How does Sight Sciences compare to InMode?

Summary

How does Sight Sciences compare to SS Innovations International?

Summary

How does Sight Sciences compare to CeriBell?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SGHT vs. The Competition

Sight Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sight Sciences (SGHT) Competitors

SGHT vs. AVR, DRTS, INMD, SSII, and CBLL

How does Sight Sciences compare to Anteris Technologies Global?

Do institutionals and insiders have more ownership in AVR or SGHT?

Do analysts prefer AVR or SGHT?

Which has stronger valuation & earnings, AVR or SGHT?

Does the media favor AVR or SGHT?

Is AVR or SGHT more profitable?

Which has more volatility & risk, AVR or SGHT?

Summary

How does Sight Sciences compare to Alpha Tau Medical?

Is SGHT or DRTS more profitable?

Do analysts prefer SGHT or DRTS?

Do institutionals & insiders have more ownership in SGHT or DRTS?

Which has higher earnings and valuation, SGHT or DRTS?

Does the media favor SGHT or DRTS?

Which has more volatility and risk, SGHT or DRTS?

Summary

How does Sight Sciences compare to InMode?

Do institutionals & insiders believe in SGHT or INMD?

Is SGHT or INMD more profitable?

Do analysts recommend SGHT or INMD?

Does the media favor SGHT or INMD?

Which has more risk and volatility, SGHT or INMD?

Which has better earnings & valuation, SGHT or INMD?

Summary

How does Sight Sciences compare to SS Innovations International?

Is SGHT or SSII more profitable?

Do analysts prefer SGHT or SSII?

Does the media prefer SGHT or SSII?

Which has higher earnings & valuation, SGHT or SSII?

Which has more volatility & risk, SGHT or SSII?

Do insiders & institutionals believe in SGHT or SSII?

Summary

How does Sight Sciences compare to CeriBell?

Does the media favor SGHT or CBLL?

Which has stronger earnings and valuation, SGHT or CBLL?

Which has more volatility & risk, SGHT or CBLL?

Do insiders and institutionals hold more shares of SGHT or CBLL?

Is SGHT or CBLL more profitable?

Do analysts recommend SGHT or CBLL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SGHT vs. The Competition

Sight Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools